PDS Biotechnology (PDSB) Treasury Shares (2014 - 2018)

PDS Biotechnology's (PDSB) quarterly Treasury Shares came in at $509962.0 in Q4 2018, down 15.2% on a QoQ basis from $601394.0 in Q3 2018.

PDS Biotechnology (PDSB) Treasury Shares (2014 - 2018) Analysis & Trends

PDS Biotechnology (PDSB) has 3 years of Treasury Shares data on file, last reported at $509962.0 in Q4 2018.

Quarterly Treasury Shares changed N/A year-over-year to $509962.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $509962.0 (changed N/A YoY) and the FY2018 annual result came in at $509962.0, changed N/A from the prior year.
Treasury Shares fell to $509962.0 in Q4 2018, from $601394.0 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $4.7 million in Q3 2015 to a low of $359935.0 in Q4 2014.
A 3-year average of $1.5 million and a median of $555678.0 in 2018 frame the typical range for Treasury Shares.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	2.72 Mn
10	PDS Biotechnology	12.02 Mn	12.02 Mn	-	-

Download Data